Medical care, high drug prices has been the focus of attention, while the prices of drugs over the years has been not let the people feel real benefits. How can a real drug prices down, how can people buy cheaper drugs by Sohu Joint Health and Health Times, invited representatives, members, experts, etc. to discuss the president.
Interview Time: 7:30
the evening of March 6 interview with the theme: how to make it easier to see a doctor?
interview guests :
extraordinary week CPPCC (Chinese Medicine Research Institute Fellow), Chinese Academy of Social Development and Regulation of the Food and Drug Industries Research Center, Zhang Jian, Wang Yongjun Tian Tan Hospital, vice president, the people of Tianjin large pharmacy manager TANG Aimin, Health Times Meng Lai editor.
interviews Record
mm a mm
automatically scroll
Sohu health: Ladies and gentlemen, good evening all their friends. Today interview topic is how can we truly drug prices down. today invited CPPCC members to the guests, the Chinese Medicine Research Institute researcher Professor Zhou Chaofan; Chinese Academy of Social Development and Regulation of the Food and Drug Industries Research Center, Zhang Jian; Tiantan Hospital, vice president Wang Yongjun; people Dispensary manager of Tianjin TANG Aimin; media representatives Healthy Times editor Meng Li. very grateful to the arrival of some guests. Today, about drugs and drug prices since the problem, Professor Zhou is a member of the scene, the other four are related to the pharmaceutical industry has a direct or indirect contact, please briefly We talk about his medical treatment is difficult and expensive encounter case?
extraordinary week CPPCC (Chinese Medicine Research Institute Fellow)
Zhang Jian: I feel about a change in drug prices, because I am in hypertensive patients the doctor asked daily medications, I'd not to get into large hospitals in the community hospital. But last month, when the doctors told me the community, you often eat more of this medicine can be opened, I said why? he said This is the last time into this medicine. antihypertensive drugs into the next batch is not this brand, nor is it the manufacturers, but the price more than doubled to exceed it. as a result of reasons, I am more interested, I asked He, you know do not know why the medicine is not cheap, and expensive drugs came in, he told me the results because the low bid did not move on the medicine. From here arise out of the question of drug prices is today discuss a problem. drug prices looked as if the price is just a simple question, but in fact it in-depth study, it is a more complex problem, is that many problems accumulate, and it is reflected in the price. I think the time from the health reported from Sohu, do such a discussion, it is very meaningful, and this is very concerned about the people, and it is surly the people's livelihood.
Sohu Health: Director Zhang said although the performance of drug prices, but relation to the nearest community health services are very concerned about the drug supply problem. Speaker Wang met a doctor is difficult and expensive cases do?
Wang Yongjun: the framers of drug prices is the Development and Reform Commission. Hospital Ye Hao, Ye Hao pharmacies Development and Reform Commission are in accordance with established standards of drug prices. I have two views on drug prices. First, there is indeed drug pricing bubble prices, this situation exists, is in need of reform. But another point of view, it is now concerned about the transition to drug prices, the ensuing waves of drug prices is the instructions, but if the price of drugs down to a very low level, the drug may be gone, no business reproduced. we all exclaimed Drug profits are so high, but do not know the process of developing drugs in the huge investment. Our country is now a serious shortage of investment in drug development, until now, rarely have their own intellectual property rights of drug, resulting in more and more in the future we more dependent on imported drugs. Our country is now the main reason there is a medical treatment is difficult and expensive low-tech, non-proprietary drugs too much, rather than a single species of high priced .2006, China approved new drug into the ten thousand varieties, so variety of drug promotion and they will leave a lot of hidden dangers of unfair competition. We in the clinical use of drugs, according to international norms, at least half of the drug should not be in China, which may be caused by the single drugs prescription prescription volume, rather than single drugs are expensive, the price is not the principal contradiction single species.
Tiantan Hospital, vice president Wang Yongjun Li Meng
health
Sohu Times health editor: So Speaker Wang to Now we have a simple analysis of what we produce your doctor or part of the reason of high drug prices. Professor Zhou, you have had this experience yourself or your people around you have had this experience?
extraordinary week: I seldom see the doctor, the issue of drug prices is not very understanding. but I am participating in the basic drugs and health insurance directory validation, is also part of the Development and Reform Commission participated in the pricing of work. Mr Speaker Wang said approval of the drug too much, response to vicious price competition is one reason. For example, reduced drug prices down NDRC now many times, each time dozens of price, a two hundred, so many varieties of drug prices is down. down after the manufacturers I felt very small profit margins, because there are many intermediate links. As a result, some drugs there is no profit, is bound to be a face-lift, or change the dosage form, could have been changed tablets capsules, granules and pills price change. medicine change the formulation of new plant, the NDRC had a chance to cut prices, so the first sale that money back. down a number of non-production, and again go generic formulations changed again to change specifications, then a face-lift market, the price went up, the enterprise also got short-term profits. the things we have experienced in 2005 is a Food and Drug Administration approved the drug case, a drug approved in 2006, 6500, 6500 we will say this. This 6500, the real drug Not a one, biological products is three, traditional Chinese medicine is 16, so strictly speaking, belong to 2006 batch of industry practices down only 19 new drugs approved. That all changed the other 6,500 formulations, otherwise change the specifications. < br> Sohu health: is the new name.
weeks of extraordinary: but there are good manufacturers, good manufacturers still insist on the production, I do not change the formulation, not imitation, do not change size, or honestly feeding, which is the responsibility of the manufacturers. so thin profits, and even some little profit, just to maintain production. Some unscrupulous companies, in order to save costs, expensive drugs do not have to. If inspection departments to measure the chemical composition of drugs, they charge with a number of other cheaper drugs.
Sohu health: a response to check.
extraordinary week: In order to check the step through, this component does not necessarily come from the honeysuckle. such as selling Salvia, testing department to test tanshinone content, they get some medicine Danshensu added, the significant cost savings, these are immoral profiteers. In this way, a lot of drugs there is no guarantee the quality, efficacy more difficult to ensure. there are some procedures for processing pharmaceuticals save do not do, so lead to inferior quality, causing adverse events. NDRC price determined by motivation is good, but 22 times reduction, and the people did not get the real benefits. So motivation should be unified with the effect of , and good intentions must have good results, it is indeed difficult. Food and Drug Administration also has difficulty, into the plant must also grant approval. will have introduced policies, such as Development and Reform Commission, Chinese Authority, the Food and Drug Administration, Health Department, etc., to manage this thing together. such as a drug is on the move last tender, but not because of price cuts profits, companies are not produced. However, they reported that face-lift back to the drug, if this is true, then firm can not be approved, to have it blocked. There are some manufacturers, is also expected to vote the rules, still a valuable drug, but there is no profit, can not let the good suffer, we should come up with policies at competitive prices to reward them, generally sell 8 dollars, high-quality drugs can be sold 9 dollars, selling 10 dollars, so as to promote the healthy development of the industry. So our policy to support, drug prices is a systematic project, should be more participation of several ministries, working together, to do a good job.
Chinese Academy of Social Development and Regulation of the Food and Drug Industries Research Center, ZHANG Jian
Sohu health: Week of members to help us a bit simple and what ministries should introduce policies to co-management of drug prices. now Tang briefly about your view of your drug prices?
TANG Aimin: cheap pharmacy because the people I worked, so basically do not go to the hospital medicines, in their own pharmacy. Frankly speaking, the price of pharmacies and hospitals does have gaps. I have two deep feelings, the first prescription is difficult to come up with some hospitals, the pharmacy to buy medicine when the prescription out to sell drugs, this is a headache, the health bureau has repeatedly stressed, can not sell prescription drugs, but the hospital is still finding ways to make prescription closure. In addition, I take their children to Children's Hospital, too long to register and queuing time at least two hours, for a office workers, their only have time on Sunday, so the medical resources distribution of some of the problems.
people Dispensary manager TANG Aimin
Tianjin Sohu health: medical treatment, or some hard feelings.
Meng Li: Hello, everybody, because the theme is called today's event how can we truly drug prices way down. In this event, Health Times, and Sohu health also made a simple survey online friends. which in this survey, two I noticed there is a relationship with us. 17.01% of the users that have high drug prices, there are 19.76% of the users that the doctor is expensive. The two options are seven types of options, ranked first, second. network can not be said the investigation is a very scientific survey, but enough to reflect the part of users to judge. on the people for the high or low drug prices, is not there to judge the two indicators, one objective is the high drug prices, the other is subjective, that is, users from personal consumption, personal income that the drug prices are expensive. I think maybe the perspective from both high and low will arrive at a consistent understanding.
Meng Li: User that high, and I think this may be with he relationship between the consumption levels. For example, vulnerable groups, laid-off workers or low income, he went to the hospital to buy medicine or treatment, he would generally say that high drug prices, because this is a relationship with his income . in the past to hold down prices did not reflect the recent sudden emergence of these problems, the focus of attention from the media, the focus of users, about the health care policy, universal health insurance is not a relationship. Imagine if everyone pharmaceutical spending, medical care expenditures are Most health insurance is to address, not your doctor, drug prices have so much of your advice. is not it also has a relationship with this factor.
people Dispensary manager TANG Aimin
TANG Aimin Tianjin: drug prices unrealistically high, it has been recognized by everyone, is a high or low contrast, can not take the drug situation in China with the United States, Western Europe country comparisons of wealth are concentrated, only compared with the previous, we look at the governance of a cold one or two thousand or hundreds, before the cold are small things. Ten years ago, how much the total expenditure on medicine, and now is, what its growth rate far higher than the GDP growth rate of social, even compared with the prices mentioned as such, it The comparison is compared with the past, such a comparison is definitely overpriced. The second is the retail price and the comparison between the cost of production is ex-factory price, it was ten-fold increase in comparison to prove that it is profiteering. As the profits flow to where to go, the authority has a good exposition. to hold down prices, I think the current situation from the Chinese point of view, is the horizontal comparison.
Zhang Jian: from consumers, the high price of drugs in patients with sensory point of view, there is two reasons. First, it is to compare drug prices with the past, the past one hundred to buy the medicine may be two or three dollars, and now can not buy those drugs, and alternative medicine may 50,60 dollars, from the higher than the price of a single product. In addition, the study found, people feel high drug prices, mainly because of excessive medical treatment, for example, a patient can open a medicine, but they take plastic bags to take back a variety of drugs, which increased spending on the drugs. In fact, the basic treatment of some diseases such as influenza without antibiotics, but our country is now very common use of antibiotics, it is very dangerous problem, the health of the whole nation is very serious consequences and harm. s Second, ex-factory price in the end we talk about drugs Gaobu Gao, depending on two elements, one is the real price, and its expected cost and corporate profits. But now the price is usually out of what is reported? survey to find out about a lot of pharmaceutical companies , reported that out of the price is quite a large includes the cost of stay in the middle of the price to do. I understand that there is a variety, the variety is pretty good I think, supposedly is more exclusive, but in fact cost only one into a 90% The price is unrealistically high. at least we know that drug prices in the profits of large pharmaceutical companies is not got.
price is very complex issue, it is a double-edged sword, high prices and hurt the public interests, the interests of harm to human health, so that more people get better treatment and drugs, low prices are hurting the interests of industry, industry is not if the atrophy is a good thing. I heard a case of foreign companies to find State authorities said the drug should they, instead of the domestic pharmaceutical drugs, the reason it is their good medicine the medicine than the domestic. so they requested to enter WTO, to be more open. I thought, if China manufacturers basically does not exist, we have to eat the Chinese foreign pharmaceutical production of drugs, do not know what the situation. In considering the price, my view is that both may be considered to maintain a balance.
drugs how price control? He is the need for a comprehensive governance reform and opening up soon for 30 years, our economic fundamentals are basically completed from a planned economy to a market economy-driven process. But we in government management, methods and even some system, I think this change is not yet complete, so they took in terms of drug prices, we see that many departments are involved in the management of drug prices, all aspects of the look is clearly the Development and Reform Commission, in fact, many policies, many ways can promote the formation or affect drug prices, but in the process, we found that the management is often fragmented. For example, there is now a widely cited data, regardless of the newspaper, from the Internet, we all refer to a data, that is, the year of Food and Drug Administration approved a more than ten thousand kinds of drugs, Food and Drug Administration specifically come out to clarify this matter, including thousands of pieces of clinical examination and approval, the real drug is approved out of over eleven hundred. from the industrial point of view speaking, from the developed view, now say the two drugs called ten, the emergence of a new drug to ten years and billions of dollars, four years ago, the multinational pharmaceutical companies are the major source of profits come from drugs, four years were gradually made generic drugs, generic drugs increased the proportion of profits, more than 50%, as new drugs are less and less profit. I This is a chemical drug.
Chinese medicine combined R & D investment is far below all A multinational pharmaceutical company. From this perspective, the competitiveness of enterprises tend to rely on variety of competition. 98% of our country, are likely to exceed this number of generic drugs, the real meaning of a new drug by the United States in the end that there is no standard, how many, Investigation Investigation to be. The industry itself needs a huge R & D investment, but now the state of their industries .2005 impossible to complete this task in the second half began, the entire pharmaceutical industry fell extreme profit growth in 2006 profit growth in the national pharmaceutical industry the second-lowest among all industries. Here there is a saying drug sector, pharmaceutical sector, as winter arrives, which is both in terms of. I think the pharmaceutical companies, a senior leader put it very well, the past practice good medicine get out, so that county can engage in a series of drug problems, etc., spend some money, to do public relations work, drugs to sell, and waiting to recover the money, feel good to do, so a lot of money and people came. suddenly found in the management of our government gradually strengthened, gradually standardized, this time found the problem. Of course, in terms of industrial organization, from top to bottom so that about six thousand pharmaceutical manufacturing enterprises, distribution enterprises still more than that and not in the countries than with the United States, only one of two hundred production or distribution companies, this number far exceeds our needs. Now, some speaking, lower drug prices, I'm afraid the efforts of various government departments, not a single policy, a single department will be able to solve the problem, in fact, has proved this point. the government 22 times lower drug prices, why cut prices to die for two reasons, the first manufacturer did little profit down, even no law in the maintenance of simple reproduction, and then quit. There is another, you drop the price later, business is a face-lift, a change in the name of re-production. As far as I know, some companies now have some back up drugs, get that done this to change that. the current policy is in the field of pharmaceutical production and R & D is completely market-oriented. But in the field of use, health services, are not entirely market-oriented, including the current health reform discussions, there are many views , there are advocates, including medical services and drugs are completely market-oriented production market. If fully borne by the state finance was probably difficult, even though our country is faster economic growth in recent years, but relies entirely on the government not realistic, unlikely. how to solve this conversion, how to solve this problem, how can ordinary people can afford to eat even medicine, to enjoy basic health care and social security, while promoting the health of our country's own industry, to health orderly development of VLSI it is common to consider three aspects.
Sohu health: should be said that the pharmaceutical industry in our country continue to regulate the process, how do make this a more reasonable price.
Zhang Jian: I believe that the drugs artificially high prices will come down, nothing but long and short, from our desire is concerned, of course, hope that this process as short as possible, so that ordinary people can afford to enjoy the service.
Meng Li: I think that speaks really justified Director Zhang, Professor Director Zhang and Wang have such earlier statement, a potential point of view, now we take the successive price adjustments does not necessarily achieve such results, many experts, including Healthy Times also published a related article, in fact, the high drug prices, whether high objective or subjective high, are from the pharmaceutical to the patient to complete the chain, and in the process, and ex-factory price of drugs added costs are not too many hospitals, mainly the profits are too high circulation.
Wang Yongjun: So this is the key. people feel your medicines your doctor for two reasons, the first over health care, mainly due to overtreatment too many varieties of Chinese medicines, I was the treatment of cerebral vascular disease, cerebrovascular disease, spending 300 million every year, at least 40% of the Chinese medicine preparations without the certificate, but all are in use, it has been out of the basic characteristics of traditional Chinese medicine, not a good clinical validation, this cost of transportation, then click on the up, day 23 of the most expensive anti-angiogenesis drug money, several hundred dollars a bottle of transfusion medicine, resulting in people over the medical doctor is difficult indeed. If treatment can reduce species down, can solve a big problem. The second question is who should pay for treatment costs, treatment costs are now a lot of people pay for their own, so we feel that your doctor is also a problem because of Social Security. As drugs are constantly updated , the total price of drugs rose certainly will not come down. But the treatment cost of protection on the hope that the Government can keep up, let people dig their own money to buy medicine. now is the people's psychological expectations and reality the distance is too large, poor people pay, monthly income of 10% to 20% are used for medicine, for life is indeed too much influence.
Sohu health: We all just talked about high drug prices, or medical expenses reasons for the high this year, we also understand the proposal of Professor Zhou is a national essential drugs list of drugs into one directory and health insurance, just President Wang also mentioned that he felt too many drug products, resulting in high drug prices results, do you think if the two combined, is not able to solve the drugs to hold down prices then?
weeks of extraordinary: in 2005 two, I made a proposal to make essential drugs list and medical insurance directory combined, the implementation of national essential drug system proposal, and later China Pharmaceutical News in July 23, Chinese Medicine reported in July 24 officially released. Why do I mention this proposal it? Medicare drug directory is the Labor & Social Security developed by the Ministry, the essential drug list is the State Food and Drug Administration, the essential drug list I participate in the development, the health insurance I also participated in the development of the directory, but I think that spending too much time, as if to that mountain Which song to sing.
Sohu health: The two directories do have relatively large difference?
extraordinary week: Generally, these two directories about 80% of the pharmaceutical species overlap. some of the basic drugs Drug directory there, there is no health insurance directory, there are a number of drugs in health care directory, there are no essential drugs list, put together about 20% .2004 is the essential drugs list, the medicine is 733 kinds of Chinese medicine is 1260, When selected, statistical methods are different, why is 733 kinds of medicine it is a different drug preparations, different specifications are to count by one. medicine for trouble, for example, Chinese medicine preparations, oral considered a , considered a capsule, pills, capsules and count as one, so much, there are 1,260.
addition to the above said that the comprehensive measures, a very important thing is to promote the national essential drug system, to develop national essential drug list, a real directory. World Health Organization in 1977, puts forward the basic health care in developing countries, the basic formulation of the directory, this year is 2007, exactly 30 years. Now with 30 years the World Health Organization efforts, more than 150 countries introduced a basic drug system. essential drugs must have several features: the first is a clinical need, Without it, to not cure sick. Second, the safe and effective. Third, easy to use. s Fourth, low prices. may have such conditions, to enter the essential drugs. our country is special, the essential drugs list in both traditional Chinese medicine, another medicine, I looked at the other 150 countries, they are not varieties of essential medicines more than 400, do not know how to count, we are 733 kinds of western species. only by a numerical example, penicillin and cephalosporins is one of a, the same specification, different forms count as one, we 733 kinds should be selected, according to the World The practice should be at 400 or so. Chinese have a question of method, for example, dosage forms, there are oral liquid, capsule, hard capsule, soft capsule, there are pills, not to 1260 planted.
I always pondering the question, how the implementation of essential drugs, that is, varieties of Chinese medicine have to come down. medicine category by 23 points, according to 9 categories of Chinese medicine points, the future co-ordination. This is a personal opinion. even the best of Western medicine but also control 400 species or so, Chinese varieties have mastered the 400 or so. This extension of the basic drug system, many problems to be solved. efficacy is the clinical need safe, effective, low prices, guaranteed supply, fixed-point production, uniform fat distribution, simplified packaging, price will come down, you want to mess about, do not. If that can promote such a system, I think drugs will be inflated to solve the problem. In addition since it is of essential drugs, medical control adverse reaction, certainly not a problem . said that adverse drug reactions are rare, occasionally, and will not be common. In actual fact, the drug now approved the first clinical 20,30 cases, 100 cases of the second phase of the clinical, the third of 100 cases adverse reactions can not tell, when coupled with the requirements of drug testing not more than 65 years, not 18 years of age, pregnant women do not, do not be feeding the children, along with liver and gallbladder disease, cardiovascular disease, are all excluded, of course, can not see adverse reactions, and drug in two or three years later, adverse reactions came out. to promote the national essential drug system, not only for developing countries to promote, and now even the developed countries began to promote, so I strongly advocate together to promote the essential drugs.
Wang Yongjun: Teacher Zhou said 400 kinds of drugs have been very relaxed, the 2008 Olympic Games is the 200 types of basic medication administration, to ensure the safety of all athletes, but also to ensure drug safety for all audiences. < br> mm b mm
Sohu health: just say that these two drugs list of hospitals and pharmacies for What is the significance? Speaker Wang you as representatives of the hospital, Tang Jingli you as a representative of the pharmacy, for a few sentence right.
Wang Yongjun: Different reimbursement with a different directory, such as a public health or health insurance, more complicated, I am sure Professor Zhou their hands in favor of the proposal, since the two directories, the doctor is very difficult to remember, and error-prone, after using the wrong drugs to hospitals and doctors need to bear the costs. I think that the synthesis of a directory as soon as possible, cut down the variety of drugs, which is to improve people's drug use an important part of your medication.
Meng Li: I have the experts In his speech, I looked out Sohu health and health Times investigation, the people that the number-one problem is that your doctor, the second is to hold down prices, in fact, two issues are carefully examined in parallel, see a doctor Your link to and hold down prices. For example your doctor, if your doctor is resolved, that live in a hospital, to the hospital for a health, their take less money to hold down prices for the problems he reflected will be reduced. This reasoning means that people always mention your doctor to hold down prices linked, but in fact the entire expenditure in the doctor, the drug prices of expenditures, the expenditure may only drugs a certain proportion. a patient during treatment, there are drugs, inspection fees, if there are more and more surgical supplies, we have reported to have published an article, a heart stents sold in foreign countries over a thousand of RMB 8 to China to become the eighteen thousand, and do not know the data whether the Right, at least in this case reflects that the people of your doctor in a certain proportion of total supplies. But there mere mention of your doctor, but this does not sound , in addition to large-scale inspection fees, CT, NMR, it has also become very important to people's medical costs increased growth.
Wang Yongjun: General Hospital medicine Hospital spending accounted for 40% to 50%, which is a large general hospital, two much lower level hospitals. Now the weight of supplies accounting for more and more, are high-quality supplies, paper supplies data on the quality certainly is accurate, this figure is much higher than many foreign figures, the same which is made NDRC pricing. how come the price, we not sure, what are given, we do not know. the same species of large growth in checking fees, the price of each do a CT does not change, surgery price has not changed for 20 years in Beijing The main varieties of new drugs is increasing, prices of medicines do constantly, and the second is the increasing application of high supplies.
Meng Li: Now people think that your hospital medicine, but that the pharmacy is cheaper, in fact, is not like that, because of health Times reporter specializing in end of 06 made a survey of about a dozen specific drugs in the Medicare drug stores, drug stores sold for higher than the hospital instead. that patients in the course of treatment, the medicine has already cured Hospital high prices, in fact, in the circulation, the drugs from pharmaceutical companies out of the hands of consumers, is that through the two channels, one hospital, one pharmacy, of course, does not include some cheap pharmacy here, like people Dispensary, I guess that is cheaper than the hospital.
Sohu Health: In general the number of pharmacies cheap drug prices lower than the hospital price?
TANG Aimin: about 80% of the products is lower than the hospital drug prices. On Medicare designated hospital pharmacy drug prices higher than the phenomenon of speaking from my experience: after the implementation of the medical insurance system, particularly as Beijing, Shanghai, such a large city on the designated pharmacy health insurance is very strict examination and approval of pharmacy access to affordable Medicare set a high threshold pharmacies, so it is more than access to health care is a state-designated pharmacy pharmacy component, coupled with a very small number of the approval to form a government monopoly of resources. Some medical insurance designated pharmacies to take advantage of this high threshold monopoly of resources, sharing of interests. So we agreed to Medicare pharmacy drug prices increased, but no one else to share with him. sentinel pharmacies to hold down prices for health care phenomenon, is that governments in particular, the labor department to release the approval threshold, so that a fully competitive pharmacy business qualifications. In addition, just mentioned, health insurance. The just mentioned Professor Zhou is a basic drug system in order to curb drug prices artificially high, these two varieties of the directory included all aspects of the interests involved, if unified, but also scholars such as Professor Zhou to call. We Professor Zhou pharmacy welcome the proposal, because, like Professor Zhou said very busy, this species is urgently needed.
Sohu health: the number of pharmacies in general parity price of goods lower than the hospital?
TANG Aimin: I can not promise success is 100%, but are basically low- drug prices in the hospital. On the Medicare designated hospital pharmacy drug prices higher than the phenomenon of speaking from my experience: after the implementation of the medical insurance system, particularly as Beijing, Shanghai, such a large city, the approval of health insurance is designated pharmacies strict, established on the cheap pharmacy into a high threshold, so the status quo is more than access to health care is a state-designated pharmacy pharmacy component, coupled with a very small number of the approval to form a government monopoly of resources. Some medical insurance designated pharmacies monopoly on the use of the high threshold of resources, sharing of interests. So we agreed to Medicare pharmacy drug prices increased, but no one else to share with him. sentinel pharmacies to hold down prices for health care phenomenon, is that governments in particular, the labor department to put On the threshold of approval, so that operating fully qualified pharmacy competition. I think if Beijing allows people into the large pharmacy health insurance designated pharmacies, I believe that Beijing Medicare pharmacy drug prices down in one night. This is the result of administrative examination and approval system The new interest groups.
addition, mentioned the health insurance. The just mentioned Professor Zhou is a basic drug system in order to curb drug prices artificially high, these two directories do your interests involved in all aspects, if unified, but also scholars such as Professor Zhou to call. We Professor Zhou pharmacy welcome the proposal, because, like Professor Zhou said very busy, this species is urgently needed.
mm c mm
Sohu health: Bangladesh total just that: drugs from manufacturer through to patient hands, nothing less than the two ways, one hospital, one is pharmacy; just President Wang also said revenue in the hospital, medicines account for about 40% to 50%; now there is a proposal mm high then?
Wang Yongjun: The government should increase investment and ...
